FOLOTYN (pralatrexate) Acrotech Patent: 6,028,071 Expiration: Jul 16, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug P…
Drug Patent Expirations for the Week of July 10, 2022 Read Post »
This chart shows the pharmaceutical companies with the most patents in Taiwan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Taiwan? Read Post »
Annual Drug Patent Expirations for BYFAVO Byfavo is a drug marketed by Acacia and is included in one NDA. There are ten patents protecting this drug. This drug has forty-four…
The post New patent for Acacia drug BYFAVO appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Veloxis Pharms drug ENVARSUS XR appeared first on Drug…
Annual Drug Patent Expirations for MAYZENT Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Novartis drug MAYZENT appeared first on DrugPaten…
Annual Drug Patent Expirations for BARHEMSYS Barhemsys is a drug marketed by Acacia and is included in one NDA. There are four patents protecting this drug. This drug has thirty-eight…
The post New patent for Acacia drug BARHEMSYS appeared first on Dru…
This chart shows the drugs with the most patents in Chile. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Chile? ap…
Which pharmaceutical drugs have the most drug patents in Chile? Read Post »
Annual Drug Patent Expirations for ULESFIA Ulesfia is a drug marketed by Shionogi Inc and is included in one NDA. There are two patents protecting this drug and one Paragraph…
The post New patent expiration for Shionogi Inc drug ULESFIA appeared first …
New patent expiration for Shionogi Inc drug ULESFIA Read Post »
This chart shows the pharmaceutical companies with the most powder dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most powder dosed drugs…
The post Which pharmaceutical companies have the most powder…
Which pharmaceutical companies have the most powder dosed drugs? Read Post »
This chart shows the pharmaceutical companies with the most patents in Poland. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Poland? Read Post »
Get new actionable insights and updates from BiotechBlog
